nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranolazine—Upset stomach—Metformin—polycystic ovary syndrome	0.0517	0.0706	CcSEcCtD
Ranolazine—Lethargy—Metformin—polycystic ovary syndrome	0.0251	0.0343	CcSEcCtD
Ranolazine—Pain in extremity—Metformin—polycystic ovary syndrome	0.0246	0.0336	CcSEcCtD
Ranolazine—Dehydration—Metformin—polycystic ovary syndrome	0.0229	0.0312	CcSEcCtD
Ranolazine—Breast disorder—Metformin—polycystic ovary syndrome	0.0222	0.0304	CcSEcCtD
Ranolazine—Cramp muscle—Metformin—polycystic ovary syndrome	0.0221	0.0303	CcSEcCtD
Ranolazine—Pancreatitis—Metformin—polycystic ovary syndrome	0.0208	0.0285	CcSEcCtD
Ranolazine—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.0204	0.0278	CcSEcCtD
Ranolazine—SCN9A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0195	0.13	CbGpPWpGaD
Ranolazine—Bevantolol—ADRA1A—polycystic ovary syndrome	0.0192	0.163	CrCbGaD
Ranolazine—Bradycardia—Metformin—polycystic ovary syndrome	0.0173	0.0237	CcSEcCtD
Ranolazine—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0169	0.0231	CcSEcCtD
Ranolazine—Oedema peripheral—Metformin—polycystic ovary syndrome	0.0168	0.0229	CcSEcCtD
Ranolazine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.0167	0.0228	CcSEcCtD
Ranolazine—Eye disorder—Metformin—polycystic ovary syndrome	0.0159	0.0217	CcSEcCtD
Ranolazine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0158	0.0216	CcSEcCtD
Ranolazine—Angiopathy—Metformin—polycystic ovary syndrome	0.0154	0.0211	CcSEcCtD
Ranolazine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.0153	0.021	CcSEcCtD
Ranolazine—Carvedilol—ADRA1D—polycystic ovary syndrome	0.0153	0.129	CrCbGaD
Ranolazine—Malnutrition—Metformin—polycystic ovary syndrome	0.0148	0.0202	CcSEcCtD
Ranolazine—Flatulence—Metformin—polycystic ovary syndrome	0.0146	0.0199	CcSEcCtD
Ranolazine—Muscle spasms—Metformin—polycystic ovary syndrome	0.0142	0.0195	CcSEcCtD
Ranolazine—Vision blurred—Metformin—polycystic ovary syndrome	0.014	0.0191	CcSEcCtD
Ranolazine—Tremor—Metformin—polycystic ovary syndrome	0.0139	0.019	CcSEcCtD
Ranolazine—Carvedilol—ADRB3—polycystic ovary syndrome	0.0137	0.116	CrCbGaD
Ranolazine—Syncope—Metformin—polycystic ovary syndrome	0.0133	0.0181	CcSEcCtD
Ranolazine—Palpitations—Metformin—polycystic ovary syndrome	0.0131	0.0179	CcSEcCtD
Ranolazine—Carvedilol—ADRA1B—polycystic ovary syndrome	0.0131	0.11	CrCbGaD
Ranolazine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.013	0.0178	CcSEcCtD
Ranolazine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0125	0.0171	CcSEcCtD
Ranolazine—SCN5A—Interaction between L1 and Ankyrins—SPTBN4—polycystic ovary syndrome	0.0122	0.0811	CbGpPWpGaD
Ranolazine—Shock—Metformin—polycystic ovary syndrome	0.0119	0.0162	CcSEcCtD
Ranolazine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.0118	0.0162	CcSEcCtD
Ranolazine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0118	0.0162	CcSEcCtD
Ranolazine—Skin disorder—Metformin—polycystic ovary syndrome	0.0117	0.016	CcSEcCtD
Ranolazine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.0117	0.016	CcSEcCtD
Ranolazine—Anorexia—Metformin—polycystic ovary syndrome	0.0115	0.0157	CcSEcCtD
Ranolazine—Bevantolol—ADRB2—polycystic ovary syndrome	0.0114	0.0966	CrCbGaD
Ranolazine—Hypotension—Metformin—polycystic ovary syndrome	0.0113	0.0154	CcSEcCtD
Ranolazine—Paraesthesia—Metformin—polycystic ovary syndrome	0.0108	0.0148	CcSEcCtD
Ranolazine—Dyspnoea—Metformin—polycystic ovary syndrome	0.0108	0.0147	CcSEcCtD
Ranolazine—Somnolence—Metformin—polycystic ovary syndrome	0.0107	0.0147	CcSEcCtD
Ranolazine—Dyspepsia—Metformin—polycystic ovary syndrome	0.0106	0.0145	CcSEcCtD
Ranolazine—Decreased appetite—Metformin—polycystic ovary syndrome	0.0105	0.0144	CcSEcCtD
Ranolazine—Propranolol—ADRB3—polycystic ovary syndrome	0.0105	0.0883	CrCbGaD
Ranolazine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.0104	0.0143	CcSEcCtD
Ranolazine—Fatigue—Metformin—polycystic ovary syndrome	0.0104	0.0142	CcSEcCtD
Ranolazine—Constipation—Metformin—polycystic ovary syndrome	0.0103	0.0141	CcSEcCtD
Ranolazine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00996	0.0136	CcSEcCtD
Ranolazine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00988	0.0135	CcSEcCtD
Ranolazine—Urticaria—Metformin—polycystic ovary syndrome	0.0096	0.0131	CcSEcCtD
Ranolazine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00955	0.0131	CcSEcCtD
Ranolazine—Carvedilol—VEGFA—polycystic ovary syndrome	0.00928	0.0784	CrCbGaD
Ranolazine—Carvedilol—ADRA1A—polycystic ovary syndrome	0.00879	0.0742	CrCbGaD
Ranolazine—Asthenia—Metformin—polycystic ovary syndrome	0.00867	0.0118	CcSEcCtD
Ranolazine—Pruritus—Metformin—polycystic ovary syndrome	0.00855	0.0117	CcSEcCtD
Ranolazine—Dizziness—Metformin—polycystic ovary syndrome	0.00799	0.0109	CcSEcCtD
Ranolazine—Vomiting—Metformin—polycystic ovary syndrome	0.00768	0.0105	CcSEcCtD
Ranolazine—Rash—Metformin—polycystic ovary syndrome	0.00762	0.0104	CcSEcCtD
Ranolazine—Dermatitis—Metformin—polycystic ovary syndrome	0.00761	0.0104	CcSEcCtD
Ranolazine—Headache—Metformin—polycystic ovary syndrome	0.00757	0.0103	CcSEcCtD
Ranolazine—SCN9A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.0075	0.05	CbGpPWpGaD
Ranolazine—Nausea—Metformin—polycystic ovary syndrome	0.00718	0.00981	CcSEcCtD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C2—polycystic ovary syndrome	0.00659	0.0439	CbGpPWpGaD
Ranolazine—Carvedilol—ADRB2—polycystic ovary syndrome	0.00523	0.0441	CrCbGaD
Ranolazine—SCN5A—L1CAM interactions—SPTBN4—polycystic ovary syndrome	0.00467	0.0311	CbGpPWpGaD
Ranolazine—Carvedilol—CYP1A1—polycystic ovary syndrome	0.00448	0.0379	CrCbGaD
Ranolazine—Propranolol—ADRB2—polycystic ovary syndrome	0.00397	0.0336	CrCbGaD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C1—polycystic ovary syndrome	0.00367	0.0244	CbGpPWpGaD
Ranolazine—Propranolol—CYP1A1—polycystic ovary syndrome	0.00341	0.0288	CrCbGaD
Ranolazine—SCN9A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00296	0.0197	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00283	0.0189	CbGpPWpGaD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—polycystic ovary syndrome	0.00282	0.0188	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00262	0.0175	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00248	0.0165	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—NRG1—polycystic ovary syndrome	0.00218	0.0145	CbGpPWpGaD
Ranolazine—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—polycystic ovary syndrome	0.00203	0.0135	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00202	0.0135	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—RUNX3—polycystic ovary syndrome	0.0019	0.0126	CbGpPWpGaD
Ranolazine—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—polycystic ovary syndrome	0.00186	0.0124	CbGpPWpGaD
Ranolazine—SCN5A—L1CAM interactions—DLG4—polycystic ovary syndrome	0.00185	0.0123	CbGpPWpGaD
Ranolazine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—polycystic ovary syndrome	0.00177	0.0118	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—SPTBN4—polycystic ovary syndrome	0.00177	0.0118	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00171	0.0114	CbGpPWpGaD
Ranolazine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00171	0.0114	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—INS—polycystic ovary syndrome	0.00156	0.0104	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—CDH15—polycystic ovary syndrome	0.00155	0.0103	CbGpPWpGaD
Ranolazine—SCN5A—Cardiac Progenitor Differentiation—IGF1—polycystic ovary syndrome	0.00151	0.0101	CbGpPWpGaD
Ranolazine—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00143	0.00954	CbGpPWpGaD
Ranolazine—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00138	0.00917	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SPTBN4—polycystic ovary syndrome	0.00126	0.00839	CbGpPWpGaD
Ranolazine—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—polycystic ovary syndrome	0.00122	0.00815	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—TH—polycystic ovary syndrome	0.00121	0.00803	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—DLG4—polycystic ovary syndrome	0.00112	0.00746	CbGpPWpGaD
Ranolazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00112	0.00745	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—AR—polycystic ovary syndrome	0.00107	0.00715	CbGpPWpGaD
Ranolazine—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00106	0.00708	CbGpPWpGaD
Ranolazine—CYP3A4—Estrogen metabolism—CYP1A1—polycystic ovary syndrome	0.00102	0.00678	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.001	0.00668	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000989	0.00659	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000939	0.00625	CbGpPWpGaD
Ranolazine—CYP3A4—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.000936	0.00623	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000932	0.00621	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000919	0.00613	CbGpPWpGaD
Ranolazine—CYP3A4—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.0009	0.006	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—NR3C1—polycystic ovary syndrome	0.000867	0.00578	CbGpPWpGaD
Ranolazine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—polycystic ovary syndrome	0.000865	0.00576	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000812	0.00541	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—DLG4—polycystic ovary syndrome	0.000799	0.00532	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000792	0.00528	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000755	0.00503	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000748	0.00499	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000737	0.00491	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000728	0.00485	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—DLG4—polycystic ovary syndrome	0.000697	0.00465	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.000655	0.00437	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.000647	0.00431	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.000614	0.00409	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.000609	0.00406	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.000601	0.00401	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000598	0.00399	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000598	0.00398	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP19A1—polycystic ovary syndrome	0.000596	0.00397	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000594	0.00396	CbGpPWpGaD
Ranolazine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000586	0.00391	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.000531	0.00354	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000522	0.00348	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—DLG4—polycystic ovary syndrome	0.000498	0.00332	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.000494	0.00329	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—ADIPOQ—polycystic ovary syndrome	0.000494	0.00329	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—LEP—polycystic ovary syndrome	0.000492	0.00328	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000487	0.00325	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.000482	0.00321	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000482	0.00321	CbGpPWpGaD
Ranolazine—CYP3A4—Tryptophan metabolism—CYP1A1—polycystic ovary syndrome	0.000481	0.0032	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.00048	0.0032	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.000476	0.00317	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—SLC2A4—polycystic ovary syndrome	0.000466	0.00311	CbGpPWpGaD
Ranolazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—polycystic ovary syndrome	0.000463	0.00308	CbGpPWpGaD
Ranolazine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000443	0.00295	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000432	0.00288	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000429	0.00286	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000426	0.00284	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—INS—polycystic ovary syndrome	0.000421	0.0028	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—VEGFA—polycystic ovary syndrome	0.000416	0.00277	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000406	0.00271	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000402	0.00268	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000401	0.00267	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000396	0.00264	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.000391	0.0026	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000389	0.00259	CbGpPWpGaD
Ranolazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000383	0.00255	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—NCOR1—polycystic ovary syndrome	0.000373	0.00248	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000372	0.00248	CbGpPWpGaD
Ranolazine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000359	0.00239	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000341	0.00227	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000319	0.00212	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000317	0.00212	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000315	0.0021	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000314	0.00209	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000313	0.00209	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—LEP—polycystic ovary syndrome	0.000307	0.00204	CbGpPWpGaD
Ranolazine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.00029	0.00193	CbGpPWpGaD
Ranolazine—SCN5A—SIDS Susceptibility Pathways—IL6—polycystic ovary syndrome	0.000288	0.00192	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000282	0.00188	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000278	0.00185	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—PPARG—polycystic ovary syndrome	0.000267	0.00178	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000266	0.00177	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000263	0.00175	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000262	0.00175	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—INS—polycystic ovary syndrome	0.000262	0.00175	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000259	0.00172	CbGpPWpGaD
Ranolazine—SCN9A—Axon guidance—IL6—polycystic ovary syndrome	0.000258	0.00172	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000256	0.00171	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—AKT2—polycystic ovary syndrome	0.000253	0.00169	CbGpPWpGaD
Ranolazine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000252	0.00168	CbGpPWpGaD
Ranolazine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000235	0.00156	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—VEGFA—polycystic ovary syndrome	0.000232	0.00155	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000225	0.0015	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000208	0.00138	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000206	0.00137	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000206	0.00137	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000205	0.00136	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000191	0.00128	CbGpPWpGaD
Ranolazine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000191	0.00127	CbGpPWpGaD
Ranolazine—SCN9A—Developmental Biology—IL6—polycystic ovary syndrome	0.000184	0.00122	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000167	0.00111	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—VEGFA—polycystic ovary syndrome	0.000166	0.0011	CbGpPWpGaD
Ranolazine—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000165	0.0011	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000163	0.00108	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000163	0.00108	CbGpPWpGaD
Ranolazine—SCN5A—Axon guidance—IL6—polycystic ovary syndrome	0.00016	0.00107	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000147	0.000981	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000136	0.000909	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000135	0.000897	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000135	0.000897	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000129	0.000861	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000125	0.000834	CbGpPWpGaD
Ranolazine—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000125	0.000831	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000123	0.000822	CbGpPWpGaD
Ranolazine—SCN5A—Developmental Biology—IL6—polycystic ovary syndrome	0.000114	0.000763	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.00011	0.000733	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000106	0.000709	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000106	0.000709	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000105	0.000699	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	9.56e-05	0.000637	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	9.35e-05	0.000623	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	9.05e-05	0.000603	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	8.92e-05	0.000594	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.45e-05	0.000563	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	8.33e-05	0.000555	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	8.07e-05	0.000538	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.06e-05	0.000537	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	7.78e-05	0.000518	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	7.47e-05	0.000498	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	7.38e-05	0.000492	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.19e-05	0.000479	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	6.97e-05	0.000464	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	6.86e-05	0.000457	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	6.86e-05	0.000457	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.25e-05	0.000417	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.11e-05	0.000407	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	5.94e-05	0.000396	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	5.92e-05	0.000394	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	5.77e-05	0.000385	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.45e-05	0.000363	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	5.43e-05	0.000362	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.28e-05	0.000352	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.09e-05	0.000339	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	4.89e-05	0.000326	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	4.85e-05	0.000323	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.82e-05	0.000322	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	4.62e-05	0.000308	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.56e-05	0.000304	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.49e-05	0.000299	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	4.38e-05	0.000292	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	4.08e-05	0.000272	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—TH—polycystic ovary syndrome	3.88e-05	0.000259	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.78e-05	0.000252	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.55e-05	0.000237	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	3.31e-05	0.00022	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	3.26e-05	0.000217	CbGpPWpGaD
Ranolazine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	3.24e-05	0.000216	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.17e-05	0.000211	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.02e-05	0.000201	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.86e-05	0.000191	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.67e-05	0.000178	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.16e-05	0.000144	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.13e-05	0.000142	CbGpPWpGaD
Ranolazine—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.12e-05	0.000141	CbGpPWpGaD
